IMPACT Therapeutics, Inc (HKG:7630)

IMPACT Therapeutics Statistics

Total Valuation

HKG:7630 has a market cap or net worth of HKD 11.76 billion. The enterprise value is 11.48 billion.

Market Cap	11.76B
Enterprise Value	11.48B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

HKG:7630 has 276.17 million shares outstanding.

Current Share Class	276.17M
Shares Outstanding	276.17M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	7.42%
Owned by Institutions (%)	15.02%
Float	92.12M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	276.39
PB Ratio	-11.04
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-34.87
EV / Sales	269.77
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-105.95

Financial Position

The company has a current ratio of 3.08

Current Ratio	3.08
Quick Ratio	2.54
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-0.06
Interest Coverage	-3.40

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-40.35%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-101.64%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	733,898
Profits Per Employee	-5.68M
Employee Count	58
Asset Turnover	0.11
Inventory Turnover	0.10

Taxes

In the past 12 months, HKG:7630 has paid 1,113 in taxes.

Income Tax	1,113
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	1,999,945

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:7630 had revenue of HKD 42.57 million and -329.31 million in losses. Loss per share was -1.44.

Revenue	42.57M
Gross Profit	40.82M
Operating Income	-259.84M
Pretax Income	-329.31M
Net Income	-329.31M
EBITDA	-258.67M
EBIT	-259.84M
Loss Per Share	-1.44

Balance Sheet

The company has 287.70 million in cash and 6.05 million in debt, with a net cash position of 281.65 million or 1.02 per share.

Cash & Cash Equivalents	287.70M
Total Debt	6.05M
Net Cash	281.65M
Net Cash Per Share	1.02
Equity (Book Value)	-1.07B
Book Value Per Share	-4.55
Working Capital	242.80M

Cash Flow

In the last 12 months, operating cash flow was -106.70 million and capital expenditures -1.68 million, giving a free cash flow of -108.38 million.

Operating Cash Flow	-106.70M
Capital Expenditures	-1.68M
Depreciation & Amortization	1.22M
Net Borrowing	-1.73M
Free Cash Flow	-108.38M
FCF Per Share	-0.39

Margins

Gross Margin	95.89%
Operating Margin	-610.43%
Pretax Margin	-773.63%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

HKG:7630 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-2.80%
FCF Yield	-0.92%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:7630 has an Altman Z-Score of -6.73 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.73
Piotroski F-Score	1